Many patients with TIA are not receiving guideline-recommended secondary prevention measures such as dual antiplatelet therapy and lipid-lowering agents, an Australian study has found. The lack of adherence to guideline recommendation was particularly noticeable for lower risk TIA patients discharged from emergency departments, an audit carried out at the Royal Brisbane and Women’s Hospital found. ...
Room for improvement on TIA secondary prevention
By Michael Woodhead
28 Jan 2021